Cargando…

Identification of fatty acid metabolism–related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma

PURPOSE: Fatty acid metabolism (FAM) affects the immune phenotype in a metabolically dynamic tumor microenvironment (TME), but the use of FAM-related genes (FAMGs) to predict the prognosis and immunotherapy response of cutaneous melanoma (CM) patients has not been investigated. In this study, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yujian, Chen, Youbai, Jiang, Weiqian, Yin, Xiangye, Chen, Dongsheng, Chi, Yuan, Wang, Yuting, Zhang, Julei, Zhang, Qixu, Han, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716430/ https://www.ncbi.nlm.nih.gov/pubmed/36466837 http://dx.doi.org/10.3389/fimmu.2022.967277

Ejemplares similares

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies
por: Xu, Yujian, et al.
Publicado: (2022)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway
por: Niu, Zehao, et al.
Publicado: (2021)

Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy
por: Wan, Qi, et al.
Publicado: (2022)

Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
por: Zhang, Wenjing, et al.
Publicado: (2022)

Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma
por: Zhang, Wengang, et al.
Publicado: (2022)

A novel inflammatory response-related signature predicts the prognosis of cutaneous melanoma and the effect of antitumor drugs
por: Xing, Jiahua, et al.
Publicado: (2022)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2023)

Cutaneous manifestations associated with immune checkpoint inhibitors
por: Watanabe, Tomoya, et al.
Publicado: (2023)

Subtyping Cutaneous Melanoma Matters
por: El Sharouni, Mary-Ann, et al.
Publicado: (2020)

Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma
por: Zhou, Xuezhi, et al.
Publicado: (2022)

Short-term influences of radiation on musculofascial healing in a laparotomy rat model
por: Chen, Youbai, et al.
Publicado: (2019)

3D-printed Model and guide plate for accurate resection of advanced cutaneous squamous cell carcinomas
por: Jiang, Weiqian, et al.
Publicado: (2023)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
por: Chen, Siteng, et al.
Publicado: (2020)

Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
por: Buder-Bakhaya, Kristina, et al.
Publicado: (2018)

9-Gene Signature Correlated With CD8(+) T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma
por: Yan, Kexin, et al.
Publicado: (2021)

Identification of Immune Function-Related Subtypes in Cutaneous Melanoma
por: Liu, Lin, et al.
Publicado: (2021)

Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
por: Liu, Qian, et al.
Publicado: (2021)

Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
por: Shi, Fuyan, et al.
Publicado: (2021)

Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy
por: Pickering, Chad, et al.
Publicado: (2023)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
por: Xu, Ya, et al.
Publicado: (2020)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Multi-omics analysis of Siglec family genes in cutaneous melanoma
por: Li, Kezhu, et al.
Publicado: (2023)

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
por: Willsmore, Zena N., et al.
Publicado: (2021)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Tumor Apolipoprotein E is a key checkpoint blocking anti-tumor immunity in mouse melanoma
por: Wu, Xiaofang, et al.
Publicado: (2022)

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
por: Wang, Xueyan, et al.
Publicado: (2022)

Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer
por: Hong, David S., et al.
Publicado: (2022)

Immune-related risk score: An immune-cell-pair-based prognostic model for cutaneous melanoma
por: Li, Mingjia, et al.
Publicado: (2023)

Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
por: Guo, Sen, et al.
Publicado: (2022)

CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
por: Liu, Jun, et al.
Publicado: (2022)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
por: Peranzoni, Elisa, et al.
Publicado: (2020)

Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
por: Wang, Xiaoqiang, et al.
Publicado: (2023)

Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
por: Salem, Deepak, et al.
Publicado: (2021)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
por: Elia, Angela Rita, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pu56spnnm6bpfvopqnlajj247c